Clinical trial
Study of the Efficacy and Safety of KALINOX® 170 Bar for the Performance of Care Procedures in Children With Burns
NCT00643357 is registered in ClinicalTrials.gov with Air Liquide Santé International as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Efficacy and Safety of KALINOX® 170 Bar for the Performance of Care Procedures in Children With Burns
- Lead sponsor
- Air Liquide Santé International
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- March 31, 2008
- Completion date
- January 31, 2009
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.